2026
2025
Letter to Physicians and Healthcare Providers- COVID-19 08-29-2025
Change in Communications 05-09-2025
Ongoing Risk of Dengue Infection 04-07-2025
Tuberculosis Information for Risk Assessment 03-28-2025
Measles Information for Clinicians 03-12-2025
2025 Healthcare Professional’s Guide to Disease Reporting in Michigan 01-02-2025
2024
2023
2022
- COVID-19 Antiviral Treatments 11-23-2022
- Health Advisory: Respiratory Syncytial Virus (RSV) 11-18-2022
- 2021 Tuberculosis Information for Risk Assessment 02-07-2022
- Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology 04-22-2022
- Health Advisory- Syphilis 05-11-2022
- Health Advisory- Monkey Pox 06-13-2022
- Monkeypox Testing Basics 07-28-2022
- Communicable Disease Reporting 10-18-2022
2021
2020
- Updated Gonorrhea Treatment Recommendations 12-30-2020
- Coronavirus (COVID-19) Advisory 03-09-2020
- Coronavirus (COVID-19) Pre-Pandemic Planning 02-27-2020
- Disseminated Gonococcal Infection Cluster Investigation 02-26-2020
- Coronavirus Situation Summary 01-31-2020
- Interim Guidance on Outbreak of 2019 Novel Coronavirus (2019-nCoV) 01-24-2020 - OBSOLETE
2019
- Permethrin 5% Stock 12-10-2019
- Gonorrhea now at urgent-threat level; mycoplasma genitlium concerns on the rise 11-21-2019
- MDHHS Offers Student Loan Repayment to Medical Professionals Who Treat Opioid Use Disorder 11-14-2019
- Healthcare Provider Role in Diagnosis and Surveillance of Vaccine Preventable Diseases 10-10-2019
- Eastern Equine Encephalitis Risk 09-19-2019
- Vaping Associated Pulmonary Illness 09-03-2019
- Legionellosis Awareness 08-21-2019
- Swine Flu 08-02-2019
- Psittacosis Awareness 07-03-2019
- Legionellosis Awareness 05-28-19
- Confirmed Measles 05-17-2019
- Measles Screening and Specimen Collection 04-30-2019
- Increased Surveillance for Measles 03-28-2019
- Increased Surveillance for Mumps 03-20-2019
- 2018 Tuberculosis Information for Risk Assessment 01-16-2019
- Norovirus 01-08-2019
2018
2017
2016
2015